Infectious Disease Physician Group Medical Billing Services

Important services include claims management, coding review, denial management, eligibility and authorization support, A/R follow-up, payment reconciliation, payer contract review, and revenue-cycle consulting. Infectious disease groups may also need workflows that address infusion, OPAT, drug claims, hospital consults, and cognitive services. The right combination depends on the practice’s service lines, staffing, payer mix, and existing billing processes.

Infectious disease revenue cycles often combine cognitive physician services with infusion, OPAT, and drug-related billing. That combination creates additional coordination across documentation, coding, authorization, medical versus pharmacy benefits, drug acquisition, administration charges, and payer contracts. A billing workflow must account for both the clinical complexity of ID care and the financial controls associated with therapies and related services.

Yes. The service catalog addresses eligibility and benefits, prior authorization, drug and administration claims, claim submission, denial appeals, payment reconciliation, and A/R follow-up for infusion and OPAT activity. It also considers the connection between referral, first dose, therapy workflow, final payment, and payer coverage. Practices can use the guidance to identify process gaps affecting reimbursement and financial sustainability.

Revenue leakage can occur through under-leveled visits, missed drug or administration charges, incomplete documentation, authorization gaps, contract issues, short-pays, and aging claims. Reporting by payer, service line, and provider can reveal denial patterns, payment trends, and A/R health. Tracing each issue back to documentation, charge capture, coding, workflow, or contract terms helps practices address causes rather than only individual claims.

Denial management begins by categorizing denials according to their underlying causes. Common areas include drug and administration coding, missing authorization, medical versus pharmacy benefit confusion, and under-documented consults. Payer-specific appeals can be supported by relevant clinical documentation, while findings should be shared with clinical, coding, and front-office teams so recurring issues can be corrected in the workflow.

When a practice buys and bills drugs, a payment variance can directly affect its financial results. Payment reconciliation compares reimbursement with expected amounts for drug, administration, and E/M claims. Reviews may identify short-pays, incorrect fee schedule application, or unit and NDC mismatches. Documenting and tracking disputes gives the practice a clearer view of underpayments and potential recovery opportunities.

Revenue-cycle consulting can help examine the workflow from referral through final payment before or during program development. The review may cover documentation, coding, eligibility, authorization, drug acquisition, infusion billing, denials, A/R, and payer or hospital coverage agreements. A prioritized plan can help group leaders and administrators understand operational dependencies and identify areas that require attention as services expand.

The resources are designed for infectious disease physicians, independent infectious disease practices, infectious disease group leaders, and medical practice administrators. They are especially relevant to groups evaluating revenue streams, infusion or OPAT operations, staffing, reimbursement, payer agreements, and revenue-cycle performance. The materials are intended to explain financial mechanics clearly while leaving practices to apply their own data and circumstances.